CLINICAL_TRIALS
research
· 2026-02-12
Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia [Phase 2]
Summary
Phase 2 clinical trial update for ALKS 2680 in idiopathic hypersomnia, currently recruiting to assess safety and effectiveness.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alkermes, Inc. | Conditions: Idiopathic Hypersomnia | Phase 2 | Status: RECRUITING